Express Pharma

Covaxin demonstrates persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants

Subjects were evaluated for safety, neutralising antibody responses against variants of concern, binding antibodies against spike protein, RBD, N proteins, and for memory T and B cell responses to demonstrate cell-mediated immunity

0 197